# US 2002/0058340 A1 · Down-regulation of single genes and simultaneous down-regulation of multiple genes by nuclear localization of RNA transcripts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058340 A1
- Document ID: US20020058340A1
- Status: Published application
- Kind: A1
- Application number: 09/921,068
- Filed: 2001-08-02
- Published: 2002-05-16
- Earliest claimed: 2000-08-02
- Inventors: Thomas E. Clemente; Paul E. Staswick; Tony L. Buhr
- Web page: https://patentgrep.com/patent/US20020058340A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/8247: {involving modified lipid metabolism, e.g. seed oil composition}
- C12N 2310/111: spanning the whole gene, or a large part of it
- C12N 2310/127: DNAzymes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method is provided for gene suppression in eukaryotes by transformation with a recombinant construct containing a promoter, at least one antisense and/or sense nucleotide sequence for the gene(s) to be suppressed, wherein the nucleus-to-cytoplasm transport of the transcription products of the construct is inhibited. In one embodiment, nucleus-to-cytoplasm transport is inhibited by the absence of a normal 3′ UTR. The construct can optionally include at least one self-cleaving ribozyme. The construct can also optionally include sense and/or antisense sequences to multiple genes that are to be simultaneously down-regulated using a single promoter. Also disclosed are vectors, plants, animals, seeds, gametes, and embryos containing the recombinant constructs.

## Claims

### Claim 1

A method for suppressing gene expression in a eukaryotic cell comprising, transforming said cell with a recombinant construct comprising, a promoter functional in said cell operatively linked to a sense nucleotide sequence of a gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 2 (depends on 1)

The method of claim 1, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 3 (depends on 1)

The method of claim 1, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a 3′ terminal sequence.

### Claim 4 (depends on 1)

The method of claim 1, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 5 (depends on 1)

The method of claim 1, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 6 (depends on 1)

The method of claim 1, wherein said construct further comprises at least one additional sense nucleotide sequence of at least one additional gene operatively linked to said promoter.

### Claim 7

A method for suppressing gene expression in a eukaryotic cell comprising, transforming said cell with a recombinant construct comprising, a promoter functional in said cell operatively linked to a plurality of antisense nucleotide sequences of a gene or genes to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 8 (depends on 7)

The method of claim 7, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 9 (depends on 7)

The method of claim 7, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a 3′ terminal sequence.

### Claim 10 (depends on 7)

The method of claim 7, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 11 (depends on 7)

The method of claim 7, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 12

A method for suppressing expression of a gene in a plant cell, comprising transforming said plant cell with a recombinant construct comprising, a promoter functional in said plant cell, and an antisense nucleotide sequence for the gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 13 (depends on 12)

The method of claim 12, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 14 (depends on 12)

The method of claim 12, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 15 (depends on 12)

The method of claim 12, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 16

A recombinant vector comprising, a promoter functional in a eukaryotic cell operatively linked to a nucleotide sequence selected from the group consisting of:
a) at least one sense nucleotide sequence of at least one gene to be suppressed,
b) a plurality of antisense nucleotide sequences of at least one gene to be suppressed, and
c) at least one antisense nucleotide sequence for at least one gene to be suppressed;
wherein nucleus-to-cytoplasm transport of transcription products of said at least one nucleotide sequence is inhibited.

### Claim 17 (depends on 16)

The recombinant vector of claim 16, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 18 (depends on 16)

The recombinant vector of claim 16, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 19 (depends on 16)

The recombinant vector of claim 16, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 20 (depends on 16)

A host cell comprising the recombinant vector of claim 16.

### Claim 21

A eukaryotic cell whose genome includes a recombinant construct comprising, a promoter functional in said eukaryotic cell operatively linked to at least one sense nucleotide sequence of at least one gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 22 (depends on 21)

The eukaryotic cell of claim 21, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a 3′ terminal sequence.

### Claim 23 (depends on 21)

The eukaryotic cell of claim 21, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 24 (depends on 21)

The eukaryotic cell of claim 21, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 25 (depends on 21)

The eukaryotic cell of claim 21, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 26 (depends on 21)

A plant comprising at least one cell of claim 21.

### Claim 27

A eukaryotic cell whose genome includes a recombinant construct comprising, a promoter functional in said eukaryotic cell operatively linked to a plurality of antisense nucleotide sequences of at least one gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 28 (depends on 27)

The eukaryotic cell of claim 27, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 29 (depends on 27)

The eukaryotic cell of claim 27, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a 3′ terminal sequence.

### Claim 30 (depends on 27)

The eukaryotic cell of claim 27, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 31 (depends on 27)

The eukaryotic cell of claim 27, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 32 (depends on 27)

A plant comprising at least one cell of claim 27.

### Claim 33

A plant cell whose genome includes a recombinant construct comprising, a promoter functional in said plant cell operatively linked to at least one antisense sequence for at least one gene to be suppressed; wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.

### Claim 34 (depends on 33)

The plant cell of claim 33, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a normal 3′ UTR.

### Claim 35 (depends on 33)

The plant cell of claim 33, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a 3′ terminal sequence.

### Claim 36 (depends on 33)

The plant cell of claim 33, wherein said construct further comprises at least one self cleaving ribozyme.

### Claim 37 (depends on 33)

The plant cell of claim 33, wherein said promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmentally regulated promoter.

### Claim 38 (depends on 33)

A plant comprising at least one cell of claim 33.

### Claim 39 (depends on 38)

A seed from the plant of claim 38.

### Claim 40 (depends on 38)

The progeny of the plant of claim 38.
